EXOSYSTEMS Inc.
Company Profile
Welcome !Welcome to our e-catalog home.Here you can find information about our products. You can also send us inquiries and post comments about our company and products. We hope you enjoy your visit.EXOSYSTEMS Inc., a 2017 spin-off from ETRI, develops AI-powered digital biomarkers that quantify neuromuscular function using evoked EMG signals. Its core technology enables the detection of muscular abnormalities and functional decline. With 70% of its team holding advanced degrees, the company holds 15 patents and has led over KRW 10 billion in national healthcare R&D. EXOSYSTEMS was also selected for Korea’s ARPA-H-equivalent program and the U.S.-based PharmStars accelerator.
Company History
| January, 2025 | Remote Therapuetic Monitoring FDA registered |
|---|---|
| January, 2024 | Selected as Global Top 4 in 'Starfinder' Hosted by Global Roche |
| January, 2023 | Recipient of the Minister of Science and ICT Award |
| March, 2022 | Selected as one of the 'Baby Unicorn 200' by the Ministry of SMEs and Startups |
| February, 2021 | Korea Roche PoC project won the Minister of SMEs and Startups Award |
| January, 2020 | CES 2020 Innovation Award Honoree in 'Health & Wellness' and 'Tech for Better World' fields |
| January, 2019 | Registered three patents on wearable rehabilitation device and program |
| January, 2017 | Company established |
Factory / Branch Office
EXOSYSTEMS Inc. (www.exosystems.io/en/rtm)
-
The person in charge
Hooman Lee -
Telephone
82-317019088 -
Fax
82-5043682311 -
Address
815 Daewangpangyo-ro Sujeong-gu, Seongnam-si, Gyeonggi-do (13449)
| Business Type | Manufacturer |
|---|---|
| Main Product | exoRehab, exoPill |
| Established | 2017-01-04 |
| Total Annual Revenue | 3~5 million (KRW) |
| Total Employees | 11~50 people |